FDA-approved most cancers, Alzheimer’s medicine missed foremost targets, research finds
One in 10 new medicine have been cleared by federal drug regulators in recent times based mostly on research that did not obtain their foremost targets, a brand new research reveals. The research by Harvard and Yale researchers discovered that of 210 new therapies accepted by the Meals and Drug Administration from 2018 via 2021,
Read More